GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Eucrates Biomedical Acquisition Corp (NAS:EUCRW) » Definitions » Total Payout Ratio

Eucrates Biomedical Acquisition (Eucrates Biomedical Acquisition) Total Payout Ratio : 0.00 (As of Jun. 14, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Eucrates Biomedical Acquisition Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Eucrates Biomedical Acquisition's current Total Payout Ratio is 0.00.


Eucrates Biomedical Acquisition Total Payout Ratio Historical Data

The historical data trend for Eucrates Biomedical Acquisition's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eucrates Biomedical Acquisition Total Payout Ratio Chart

Eucrates Biomedical Acquisition Annual Data
Trend Dec20 Dec21 Dec22
Total Payout Ratio
- - 38.51

Eucrates Biomedical Acquisition Quarterly Data
Aug20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Eucrates Biomedical Acquisition's Total Payout Ratio

For the Shell Companies subindustry, Eucrates Biomedical Acquisition's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eucrates Biomedical Acquisition's Total Payout Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Eucrates Biomedical Acquisition's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Eucrates Biomedical Acquisition's Total Payout Ratio falls into.



Eucrates Biomedical Acquisition Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Eucrates Biomedical Acquisition's Total Payout Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-93.191 + 0 + 0) / 2.42
=38.51

Eucrates Biomedical Acquisition's Total Payout Ratio for the quarter that ended in Dec. 2022 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / 0.142
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eucrates Biomedical Acquisition Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Eucrates Biomedical Acquisition's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eucrates Biomedical Acquisition (Eucrates Biomedical Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
250 West 55th Street, Suite 13D, New York, NY, USA, 10019
Website
Eucrates Biomedical Acquisition Corp is a blank check company.

Eucrates Biomedical Acquisition (Eucrates Biomedical Acquisition) Headlines